Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
14.6%
% of GNOM's 41 holdings also in GERM
11.1%
% of GERM's 54 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus GERM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in GERM |
Overlap | |
|---|---|---|---|---|
 |
MODERNA, INC. | 4.5% | 7.3% | 4.5% |
 |
BIONTECH SE SPONSORED ADR | 3.1% | 6.5% | 3.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.1% | 6.3% | 3.1% |
|
VIR BIOTECHNOLOGY, INC. | 1.3% | 2.8% | 1.3% |
|
GILEAD SCIENCES INC | 1.5% | 0.9% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to GERM
 |
ENI SPA-SPONSORED ADR | 7.7% |
|
NATERA INC | 7.3% |
|
CRISPR THERAPEUTICS AG | 4.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | 4.4% |
|
AGILENT TECHNOLOGIES INC | 4.4% |
|
BIOMARIN PHARMACEUTICAL INC | 3.7% |
|
SAREPTA THERAPEUTICS INC | 3.7% |
|
QIAGEN NV | 3.6% |
|
ILLUMINA INC | 3.5% |
|
BIO-TECHNE CORPORATION | 3.5% |
GNOM Underweight Relative to GERM
|
QUEST DIAGNOSTICS | -6.8% |
|
LABORATORY CRP OF AMER HLDGS | -6.2% |
|
IMMUNITYBIO INC | -4.9% |
|
DYNAVAX TECHNOLOGIES CORP | -4.0% |
|
BIO-RAD LABORATORIES-CL A | -3.8% |
|
QUIDEL CORP | -3.8% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | -3.7% |
|
VAXCYTE, INC. | -3.6% |
|
BIONTECH SE SPONSORED ADR | -3.4% |
|
ALNYLAM PHARMACEUTICALS INC | -3.2% |